Skip to main content Back to Top
Advertisement

8/1/2018

Amoxicillin and Clavulanate 1000 mg/62.5 mg Extended-Release Tablets

Products Affected - Description

    • Augmentin XR oral extended release tablet, Dr. Reddy's, 1000 mg / 62.5 mg, 28 count, NDC 43598-0020-28
    • Augmentin XR oral extended release tablet, Dr. Reddy's, 1000 mg / 62.5 mg, 40 count, NDC 43598-0020-40
    • Amoxicillin and Clavulanate oral extended release tablet, Dr. Reddy's, 1000 mg / 62.5 mg, 28 count, NDC 43598-0220-28
    • Amoxicillin and Clavulanate oral extended release tablet, Dr. Reddy's, 1000 mg / 62.5 mg, 40 count, NDC 43598-0220-40

Reason for the Shortage

    • Dr. Reddy's is no longer manufacturing amoxicillin/ clavulanate extended-release tablets.
    • Sandoz has amoxicillin/ clavulanate extended-release tablets available.

Available Products

    • Amoxicillin and Clavulanate oral extended release tablet, Sandoz, 1000 mg / 62.5 mg, 28 count, NDC 00781-1943-82
    • Amoxicillin and Clavulanate oral extended release tablet, Sandoz, 1000 mg / 62.5 mg, 40 count, NDC 00781-1943-39

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated August 1, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 9, 2016 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins